Amidochelocardin Overcomes Resistance Mechanisms Exerted on Tetracyclines and Natural Chelocardin
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Amidochelocardin Overcomes Resistance Mechanisms Exerted on Tetracyclines and Natural Chelocardin
Authors
Keywords
-
Journal
Antibiotics-Basel
Volume 9, Issue 9, Pages 619
Publisher
MDPI AG
Online
2020-09-18
DOI
10.3390/antibiotics9090619
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Over-expression of RamA, which regulates production of the MDR efflux pump AcrAB-TolC, increases mutation rate and influences drug-resistance phenotype.
- (2020) Elizabeth M. Grimsey et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
- (2020) David J. Newman et al. JOURNAL OF NATURAL PRODUCTS
- Mechanism of Eravacycline Resistance in Clinical Enterococcus faecalis Isolates From China
- (2020) Zewen Wen et al. Frontiers in Microbiology
- Eravacycline susceptibility was impacted by genetic mutation of 30S ribosome subunits, and branched-chain amino acid transport system II carrier protein, Na/Pi cotransporter family protein in Staphylococcus aureus
- (2020) Zhanwen Wang et al. BMC MICROBIOLOGY
- The Clinical Significance of High Antimicrobial Resistance in Community-Acquired Urinary Tract Infections
- (2020) Maria G. Zavala-Cerna et al. Canadian Journal of Infectious Diseases & Medical Microbiology
- Mechanism of eravacycline resistance in Acinetobacter baumannii mediated by a deletion mutation in the sensor kinase adeS, leading to elevated expression of the efflux pump AdeABC
- (2020) Yue Shi et al. INFECTION GENETICS AND EVOLUTION
- Tetracycline-inactivating enzymes from environmental, human commensal, and pathogenic bacteria cause broad-spectrum tetracycline resistance
- (2020) Andrew J. Gasparrini et al. Communications Biology
- Engineering Atypical Tetracycline Formation in Amycolatopsis sulphurea for the Production of Modified Chelocardin Antibiotics
- (2019) Tadeja Lukežič et al. ACS Chemical Biology
- Omadacycline: a novel aminomethylcycline
- (2019) Rodrigo M Burgos et al. Infection and Drug Resistance
- Antibiotics: past, present and future
- (2019) Matthew I Hutchings et al. CURRENT OPINION IN MICROBIOLOGY
- In vitro Activity and Heteroresistance of Omadacycline Against Clinical Staphylococcus aureus Isolates From China Reveal the Impact of Omadacycline Susceptibility by Branched-Chain Amino Acid Transport System II Carrier Protein, Na/Pi Cotransporter Family Protein, and Fibronectin-Binding Protein
- (2019) Bing Bai et al. Frontiers in Microbiology
- Semisynthesis and biological evaluation of amidochelocardin derivatives as broad-spectrum antibiotics
- (2019) Charlotte Grandclaudon et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Tetracycline-Inactivating Enzymes
- (2018) Jana L. Markley et al. Frontiers in Microbiology
- Fluoroquinolone Restriction as an Effective Antimicrobial Stewardship Intervention
- (2018) Kimberly C. Claeys et al. Current Infectious Disease Reports
- The pSG5-based thermosensitive vector family for genome editing and gene expression in actinomycetes
- (2018) Günther Muth APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- Urinary Tract Infections
- (2018) Rachel Millner et al. PEDIATRIC CLINICS OF NORTH AMERICA
- ABySS 2.0: resource-efficient assembly of large genomes using a Bloom filter
- (2017) Shaun D. Jackman et al. GENOME RESEARCH
- DnrI of Streptomyces peucetius binds to the resistance genes, drrAB and drrC but is activated by daunorubicin
- (2017) Francis Prija et al. JOURNAL OF BASIC MICROBIOLOGY
- Multi-drug-resistant Gram-negative bacteria causing urinary tract infections: a review
- (2017) Annarita Mazzariol et al. JOURNAL OF CHEMOTHERAPY
- Regulation of the AcrAB-TolC efflux pump in Enterobacteriaceae
- (2017) Natasha Weston et al. RESEARCH IN MICROBIOLOGY
- Dual mechanism of action of the atypical tetracycline chelocardin
- (2016) Jennifer J. Stepanek et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Current perspectives on tigecycline resistance in Enterobacteriaceae: susceptibility testing issues and mechanisms of resistance
- (2016) Spyros Pournaras et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Step-Wise Increase in Tigecycline Resistance in Klebsiella pneumoniae Associated with Mutations in ramR, lon and rpsJ
- (2016) Li Fang et al. PLoS One
- Construction of a New Class of Tetracycline Lead Structures with Potent Antibacterial Activity through Biosynthetic Engineering
- (2015) Urška Lešnik et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Urinary tract infections: epidemiology, mechanisms of infection and treatment options
- (2015) Ana L. Flores-Mireles et al. NATURE REVIEWS MICROBIOLOGY
- Tetracycline antibiotics and resistance mechanisms
- (2014) Fabian Nguyen et al. BIOLOGICAL CHEMISTRY
- Current and future treatment options for infections caused by multidrug-resistant Gram-negative pathogens
- (2014) Garyphallia Poulakou et al. Future Microbiology
- Structure of the AcrAB–TolC multidrug efflux pump
- (2014) Dijun Du et al. NATURE
- A new strategy to fight antimicrobial resistance: the revival of old antibiotics
- (2014) Nadim Cassir et al. Frontiers in Microbiology
- Developing new antibacterials through natural product research
- (2013) Herbert A Kirst Expert Opinion on Drug Discovery
- Clinical relevance of the ESKAPE pathogens
- (2013) Jack N Pendleton et al. Expert Review of Anti-Infective Therapy
- RamA, which controls expression of the MDR efflux pump AcrAB-TolC, is regulated by the Lon protease
- (2013) V. Ricci et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Identification of the chelocardin biosynthetic gene cluster from Amycolatopsis sulphurea: a platform for producing novel tetracycline antibiotics
- (2013) T. Lukezic et al. MICROBIOLOGY-SGM
- Effect of Transcriptional Activators SoxS, RobA, and RamA on Expression of Multidrug Efflux Pump AcrAB-TolC in Enterobacter cloacae
- (2012) Astrid Pérez et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data
- (2012) M. Kearse et al. BIOINFORMATICS
- Antibiotics produced by Streptomyces
- (2012) Rudi Emerson de Lima Procópio et al. Brazilian Journal of Infectious Diseases
- In Vitro Selection oframRandsoxRMutants Overexpressing Efflux Systems by Fluoroquinolones as Well as Cefoxitin in Klebsiella pneumoniae
- (2011) Suzanne Bialek-Davenet et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Revisiting “Older” Antimicrobials in the Era of Multidrug Resistance
- (2011) Jason M Pogue et al. PHARMACOTHERAPY
- ramR Mutations in Clinical Isolates of Klebsiella pneumoniae with Reduced Susceptibility to Tigecycline
- (2010) M. Hentschke et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Daunorubicin efflux in Streptomyces peucetius modulates biosynthesis by feedback regulation
- (2010) Padmanabhan Srinivasan et al. FEMS MICROBIOLOGY LETTERS
- Drug transport mechanism of the AcrB efflux pump
- (2009) Klaas M. Pos BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Decreased fluoroquinolone susceptibility in mutants of Salmonella serovars other than Typhimurium: detection of novel mutations involved in modulated expression of ramA and soxS
- (2009) C. Kehrenberg et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Multiple Regulatory Pathways Associated with High-Level Ciprofloxacin and Multidrug Resistance in Salmonella enterica Serovar Enteritidis: Involvement of ramA and Other Global Regulators
- (2008) E. O'Regan et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- ramR Mutations Involved in Efflux-Mediated Multidrug Resistance in Salmonella enterica Serovar Typhimurium
- (2008) Y. M. Abouzeed et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
- (2008) Helen W. Boucher et al. CLINICAL INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started